Savara, Inc. (SVRA)
4.72
-0.27
(-5.41%)
USD |
NASDAQ |
Nov 12, 16:00
4.79
+0.07
(+1.48%)
After-Hours: 20:00
Savara Market Cap : 970.13M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 970.13M |
| November 11, 2026 | 1.026B |
| November 10, 2026 | 1.011B |
| November 09, 2026 | 1.038B |
| November 06, 2026 | 992.74M |
| November 05, 2026 | 900.25M |
| November 04, 2026 | 957.16M |
| November 03, 2026 | 975.65M |
| November 02, 2026 | 971.54M |
| October 30, 2026 | 990.03M |
| October 29, 2026 | 1.017B |
| October 28, 2026 | 1.031B |
| October 27, 2026 | 998.24M |
| October 26, 2026 | 928.41M |
| October 23, 2026 | 866.79M |
| October 22, 2026 | 932.51M |
| October 21, 2026 | 959.22M |
| October 20, 2026 | 977.70M |
| October 19, 2026 | 951.00M |
| October 16, 2026 | 914.03M |
| October 15, 2026 | 973.59M |
| October 14, 2026 | 977.70M |
| October 13, 2026 | 981.81M |
| October 12, 2026 | 994.13M |
| October 09, 2026 | 1.011B |
| Date | Value |
|---|---|
| October 08, 2026 | 992.08M |
| October 07, 2026 | 1.002B |
| October 06, 2026 | 955.11M |
| October 05, 2026 | 981.81M |
| October 02, 2026 | 987.97M |
| October 01, 2026 | 1.036B |
| September 30, 2026 | 1.060B |
| September 29, 2026 | 1.043B |
| September 28, 2026 | 1.041B |
| September 25, 2026 | 1.027B |
| September 24, 2026 | 1.041B |
| September 23, 2026 | 1.027B |
| September 22, 2026 | 1.089B |
| September 21, 2026 | 1.119B |
| September 18, 2026 | 1.103B |
| September 17, 2026 | 1.113B |
| September 16, 2026 | 1.054B |
| September 15, 2026 | 1.080B |
| September 14, 2026 | 1.097B |
| September 11, 2026 | 1.089B |
| September 10, 2026 | 1.093B |
| September 09, 2026 | 1.112B |
| September 08, 2026 | 1.136B |
| September 04, 2026 | 1.103B |
| September 03, 2026 | 1.103B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.134B |
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| Anika Therapeutics, Inc. | 184.97M |
| Vericel Corp. | 2.931B |
| Biogen, Inc. | 37.02B |
Market Cap Related Metrics
| PEG Ratio | -0.5603 |
| Price to Book Value | 8.995 |
| Price | 4.72 |
| Earnings Yield | -12.90% |
| PEGY Ratio | -0.5603 |